We are live on
!
Find out more
Rhythm Pharmaceuticals
RYTM
RYTM
285 hedge funds and large institutions have $6.42B invested in Rhythm Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 101 increasing their positions, 89 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
776% more call options, than puts
Call options by funds: $16.4M | Put options by funds: $1.87M
25% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 51
13% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 89
2% more funds holding
Funds holding: 279 → 285 (+6)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
1.43% less ownership
Funds ownership: 109.17% → 107.74% (-1.4%)
18% less capital invested
Capital invested by funds: $7.8B → $6.42B (-$1.38B)
Holders
285
Holders Change
+6
Holders Change %
+2.15%
% of All Funds
3.51%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
64
Increased
101
Reduced
89
Closed
51
Calls
$16.4M
Puts
$1.87M
Net Calls
+$14.5M
Net Calls Change
+$1.06M
Top Buyers
Top Sellers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$311M |
| 2 |
Jennison Associates
New York
|
-$98.3M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$82.5M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$32.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.3M |
